Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

COVID-19

 

Efficiency innovations becoming added-value for oxygen suppliers

Many oxygen suppliers have been continuously hostile to innovation that could make delivery more efficient, HBI hears. The pandemic has renewed attention on supply, pricing and patient outcomes leading to some to reassess the approach. HBI speaks to one medical device company that claims to save up to 80% of oxygen for an inpatient. 

NHS uses COVID surge capacity amidst private pay resurgence

NHS England trusts have triggered clauses granting full access to private hospital capacity in some areas as COVID-19 hospitalisations soar, amidst controversy over the ramp-up of private pay activity - although private operators tell HBI they are focusing on time-critical surgery and cancer care.

Big Picture: Europe’s Ophthalmology Market

Topics include: Bouncing back from the financial hit of COVID as business becomes brisker Meeting pent-up demand, and the need to relieve pressure on public waiting lists How to persuade payors of the benefits of technology – the advantage of digital pathways Post-COVID consolidation pushes and opportunities; is bigger always beautiful? Panel includes: Tobias Koesters, Partner, […]

Lockdown and Zoom create cosmetic boom

Demand for aesthetic surgical procedures and cosmetic dentistry is on the rise, fuelled by both a Zoom meeting culture where everyone is aware of their appearance on camera, and the lockdown enabling otherwise undisguisable procedures to remain hidden during recovery.

Denmark tenders €200m lab services for COVID-19

The Danish regions want to spend just over €201m on collection and analysis services for COVID-19 PCR and antigen tests. This is more than 13x what the market's largest players - Unilabs and Synlab - earnt in the market in 2019.

HBI 2020: The future of domiciliary homecare – meeting an insatiable demand

In many markets there is a growing, perhaps even an insatiable demand for unskilled homecare. Is it a sector where it is possible to make money, and how? Is reimbursement sufficient? How do you attract and retain staff? And what effect is COVID having on the market? An expert panel at HBI 2020 considered all this, together with the biggest risks, and best opportunities, as we all dare to look forward to a more normal life in 2021.

HBI 2020: Investor interest in hospitals increases while outpatient valuations drop

Investors from varied backgrounds - infrastructure, private equity, and REIT, are all bullish about the prospects for healthcare investment in 2021, according to a panel of experts speaking at the HBI 2020 European Investment Panel discussion. But the pandemic may have 'readjusted the relative value discussion across sectors' according to one private equity investor.

HBI 2020: Medtech and services – new partnerships and opportunities

The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.

Find Us